Yazar "Buyukasik, Y." için listeleme

Toplam kayıt 4, listelenen: 1-4

Chronic Lymphocytic Leukemia Md Anderson Cancer Center Prognostic Index Is Successful But Still Can Be Improved By Incorporating Serum Ldh Level

Gunes, G.; Buyukasik, Y.; Aslan, N. Alayvaz; Malkan, U. Y.; Haznedaroglu, I. C.; Demiroglu, H.; Sayinalp, N. (Ferrata Storti Foundation, 2015)

…
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for acute leukaemia patients: a single centre experience [Meeting Abstract]

Goker, H.; Ozdemir, E.; Uz, B.; Buyukasik, Y.; Turgut, M.; Serefhanoglu, S.; Ozcebe, O. I. (Nature Publishing Group, 2013)

…
Generic Imatinib Mesylate Is As Effective As Original Glivec in the Management of Cml

Aksu, S.; Aktimur, S. H.; Arica, D. C.; Atay, H.; Bektas, O.; Buyukasik, Y.; Haznedaroglu, I. C. (Ferrata Storti Foundation, 2015)

…
Lenalidomide provide better progression free survival than thalidomide and bortezomib in the first relapse of multiple myeloma patients after autologous transplantation

Malkan, U.; Buyukasik, Y.; Demiroglu, H.; Ciftciler, R.; Gunes, G.; Okay, M.; Goker, H. (Pergamon-Elsevier Science Ltd, 2018)

…